ASO Visual Abstract: Change in Biomarker Profile After Neoadjuvant Chemotherapy is Prognostic and is Common in Patients with HER2+ Breast Cancer
Authors:
- 19 August 2024
- journal article
- editorial
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 31 (12) , 8126-8127